Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/36741
Type
ArticleCopyright
Open access
Collections
- INI - Artigos de Periódicos [3488]
Metadata
Show full item record
OPTOCHIASMATIC TUBERCULOMA AS THE SOLE MANIFESTATION OF LATE RECURRENT TUBERCULOSIS
Author
Affilliation
National Institute of Cancer. Department of Neurosurgery. Rio de Janeiro, RJ, Brazil.
National Institute of Cancer. Department of Radiology. Rio de Janeiro, RJ, Brazil.
Fundação Oswaldo Cruz. Instituto de Pesquisa Clínica Evandro Chagas. Laboratório de Pesquisa Clínica em Oftalmologia Infecciosa. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto de Pesquisa Clínica Evandro Chagas. Tuberculosis Research Laboratory. Rio de Janeiro, RJ, Brasil.
National Institute of Cancer. Department of Radiology. Rio de Janeiro, RJ, Brazil.
Fundação Oswaldo Cruz. Instituto de Pesquisa Clínica Evandro Chagas. Laboratório de Pesquisa Clínica em Oftalmologia Infecciosa. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto de Pesquisa Clínica Evandro Chagas. Tuberculosis Research Laboratory. Rio de Janeiro, RJ, Brasil.
Abstract
Brain tuberculomas account for 10-20% of space occupying brain lesions in developing countries. Most lesions are observed at time of tuberculosis diagnosis or soon after starting treatment. We herein describe a 32 year-old patient with a 14-month history of headache and progressive visual loss. Her past medical history revealed pulmonary tuberculosis treated eight years before. A brain MRI showed a T1- and T2-weighted isointense contrast-enhancing lesion in the optic chiasm. A presumptive diagnosis of optochiasmatic tuberculoma was made and isoniazid, rifampin, pyrazinamide, and ethambutol were started. Despite treatment, the patient evolved to blindness. The prompt recognition of this condition is extremely important since the presence of optochiasmal enhancement is associated with blindness in patients with tuberculosis.
Share